Commission writes to EU panel on industry concerns over uniformity in device labelling
This article was originally published in SRA
Executive Summary
The European Commission's Directorate General for Health and Consumer Policy (DG Sanco) has written to the EU medical device Central Management Committee regarding the latter's Decision No 3 on device labelling1. This decision, issued in July 2011, requires the full postal address of manufacturers and authorised representatives to be placed on medical devices2.